U.S. Retail REITs Stock News

Over the last 7 days, the United States market has remained flat, yet it is up 17% over the past year with earnings forecasted to grow by 18% annually. In this environment, dividend stocks offering yields of up to 5% can be appealing for investors seeking both income and potential growth.

Recent Share Performance Sets the Stage for Barrick Mining Stock Discussion Barrick Mining (B) has drawn attention after a recent 1 day gain of about 4.2%, following a period in which the stock declined around 9.8% over the past month and 10.7% over the past 3 months. See our latest analysis for Barrick Mining. For context, Barrick Mining's share price is at US$36.37 after the recent 1 day gain, but the stock is still down over the year to date. Longer term total shareholder returns over 1, 3...

S&P Global (NYSE:SPGI) has introduced Adaptive Retrieval, a service that lets customer AI agents and large language models query and assemble licensed S&P Global data using natural language. S&P Dow Jones Indices and Pantera Capital have launched a new digital asset index aimed at institutional investors. S&P Global sits at the intersection of data, analytics, and benchmarks, and these launches tie directly to that core business. Adaptive Retrieval gives clients a new way to work with the...

Honeywell International stock has just gone through a sharp pullback over the past month, while the valuation checks lean toward the shares not being a clear bargain. This sets up a tension between recent price weakness and what the broader metrics are signaling. Over the past month, Honeywell International is down 49.8%, which is a large move that forces investors to reassess whether the new price fairly reflects the fundamentals. On one side, the acquisition of Johnson Matthey’s Catalyst...

Teradyne (TER) is back in focus as Wall Street gears up for its June 2026 quarter earnings report, with expectations for significantly higher earnings per share and revenue compared with the prior year. See our latest analysis for Teradyne. Teradyne’s recent 12.07% 1 day share price gain to $374.04 comes after a softer 30 day share price return, which declined 14.59%. However, the year to date share price return of 80.21% and 1 year total shareholder return of around 4x suggest momentum has...

PriceSmart earnings: what the latest figures tell investors PriceSmart (PSMT) recently reported third quarter and nine month results that showed higher revenue and net income compared with the same periods a year earlier, putting fresh focus on the stock after the filing. For the third quarter ended May 31, 2026, PriceSmart reported revenue of US$1,481.79 million and net income of US$39.69 million, with basic and diluted earnings per share from continuing operations of US$1.28. See our latest...

Covenant Logistics Group (CVLG) has drawn fresh attention after a strong recent share price move, with the stock up 2.9% in the past day and 7.4% over the past week. See our latest analysis for Covenant Logistics Group. That short-term jump in Covenant Logistics Group’s share price sits on top of a much stronger trend, with a 30-day share price return of 17.01% and a year-to-date share price return of 123.68%. The 1-year total shareholder return of 108.92% and 5-year total shareholder return...

PagSeguro Digital (NYSE:PAGS) has drawn investor attention after recent share price moves, prompting a closer look at how its current trading levels compare with reported earnings, revenue and its broader performance record. See our latest analysis for PagSeguro Digital. At the latest share price of $9.58, PagSeguro Digital has seen short term momentum pick up, with a 1 month share price return of 8.62%, even though the 3 month share price return is down 10.97% and the 5 year total...

NIO’s share price has fallen about 88% over the past five years, yet valuation checks now show a mixed picture, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model sitting close to the current price while market multiples still screen the stock as undervalued. Over five years, NIO is down about 88%, which means any valuation case today is being made against a backdrop of very weak long-term returns. Analyst optimism around stronger vehicle deliveries, higher margins and...

Earlier this month, Forte Biosciences reported positive double-blind, placebo-controlled phase 1b results for FB102 in vitiligo, showing statistically significant facial repigmentation and a favorable safety profile across 43 patients. Importantly, many FB102-treated subjects continued to improve even after the 12-week dosing period ended, suggesting a potentially durable treatment effect out to week 24. We will now examine how FB102’s statistically significant FVASI improvement and...

Earlier in 2026, Coeur Mining, Inc. announced an update on its exploration programs at the Palmarejo and Las Chispas gold-silver operations in Mexico, committing US$158 million to its largest-ever drilling budget focused on resource growth and mine life extension. The company highlighted especially strong drilling results in Palmarejo’s Eastern District and the Gap Zone at Las Chispas, pointing to the potential for meaningful near-term reserve additions and a stronger long-term production...

MSCI Inc. has reported its second-quarter 2026 results, with sales rising to US$867 million from US$772.7 million a year earlier and net income increasing to US$342 million from US$303.7 million, alongside higher earnings per share. Alongside these results, MSCI highlighted expanding AI-led tools, new product launches, and a growing private-markets platform, signaling a deeper push into data and analytics for less transparent asset classes. Next, we’ll examine how MSCI’s strong earnings and...

Sprouts Farmers Market stock has delivered a strong 202.5% return over the past 5 years, yet its current checks still point to shares screening as undervalued on several key measures. Over 5 years, Sprouts Farmers Market has returned 202.5%, which puts the recent pullback into context as a longer term compounding story rather than a short term trade. For valuation, the main support can come from the company sustaining healthy cash generation and margins, while a key risk is any pressure on...

Recent performance context for Dillard's stock Dillard's (DDS) has seen mixed share performance recently, with the stock up over the past day and month, but down over the past 3 months and year to date, prompting closer attention from investors. See our latest analysis for Dillard's. At the current share price of $568.27, Dillard's has posted a 7.75% 7 day share price return and a 2.42% 30 day share price return, but the 90 day share price return is down 6.69% and the year to date share price...

We feel now is a pretty good time to analyse BioHarvest Sciences Inc.'s ( NASDAQ:BHST ) business as it appears the...

Bristol-Myers Squibb (BMY) is back in focus after the FDA accepted its New Drug Application for mezigdomide in relapsed or refractory multiple myeloma, alongside a new AI collaboration with Nvidia for drug discovery. See our latest analysis for Bristol-Myers Squibb. The recent FDA filing for mezigdomide and the AI expansion with Nvidia come as Bristol-Myers Squibb’s share price has gained momentum, with a 12.83% 1 month share price return and 13.97% year to date, while the 1 year total...

Bank of America recently added Keurig Dr Pepper (KDP) to its U.S. 1 List, drawing fresh attention to the beverage company’s stock and its mix of coffee, soft drinks, and other consumer drinks. See our latest analysis for Keurig Dr Pepper. The recent addition of Keurig Dr Pepper to Bank of America’s U.S. 1 List comes after a period where the stock’s 90 day share price return rose 13.83%, while its 1 year total shareholder return declined 7.56%. This combination suggests improving short term...

We'd be surprised if The Greenbrier Companies, Inc. ( NYSE:GBX ) shareholders haven't noticed that the Senior VP...

The investors in Frequency Electronics, Inc. 's ( NASDAQ:FEIM ) will be rubbing their hands together with glee today...

Morgan Stanley recently raised concerns about Vertex’s ability to reach its end-market potential amid a transition period and rising artificial intelligence pressures in tax compliance technology. The commentary highlights that AI is emerging not just as a tool but also as a competitive threat that could reshape the tax automation landscape for Vertex. We’ll now examine how Morgan Stanley’s AI-related growth concerns may influence Vertex’s existing investment narrative around...

PPL (PPL) is drawing investor attention after outlining a planned US$23 billion investment program through 2029, supported by disciplined cost management and closely tied to its current earnings guidance. See our latest analysis for PPL. Despite the fresh US$23 billion investment plan and grid upgrade story, PPL's recent momentum has softened, with the share price down over the past quarter. However, the 3 year total shareholder return of 40.04% and 5 year total shareholder return of 47.30%...

Progyny stock has climbed 40.3% over the past year, and investors now face a clear split between valuation signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to around 50% upside while market multiples suggest the shares screen as expensive. Over the last 12 months, Progyny has delivered a 40.3% return, which puts more pressure on today’s buyers to judge whether that performance already reflects the good news in the price. Recent analyst upgrades tied to stronger...

Recent Trading Context For CRISPR Therapeutics Stock CRISPR Therapeutics (NasdaqGM:CRSP) has been trading with mixed short term moves, rising about 2.5% over the past day while declining around 4.6% over the past week and 11% over the past month. See our latest analysis for CRISPR Therapeutics. At a share price of $48.15, CRISPR Therapeutics has seen short term share price pressure, with the 30 day share price return down 10.98% and the year to date share price return down 10.45%, alongside a...

CME Group stock has given investors a solid 5 year return, yet current checks suggest it is not obviously cheap, with the Excess Returns intrinsic value estimate sitting close to the market price while earnings based multiples point to a premium. CME Group has returned about 37% over the past 5 years, which is respectable but not a runaway result that clearly justifies paying any price. New product launches such as Treasury Link and expanded agriculture contracts can support long term fee...